March 9, 2020

Sysmex Corporation

Announcement of Organizational and Personnel Changes

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) announces today its decision to implement organizational and personnel changes, effective April 1, 2020, as detailed below. Targeting sustainable growth for the Group, the organizational changes aim to enhance the business development structure to accelerate strategy deployment and reinforce the Group's governance structure to enhance management quality.

1 Organizational Changes

  1. Reinforcing the Business Development Structure
    1. Augmenting Functions Related to Sales, Services and IT Products Leveraging Next- Generation Information Technologies
      • We will establish the Caresphere Innovation Division to spearhead planning and promotion with a view to fostering digital innovation in the sales, service and IT domains by leveraging our Caresphere™ network solution.
    2. Strengthening Clinical Development Capabilities in the Life Science (LS) Field
      • In the aim of accelerating the provision of products and services with new diagnostic technologies, we will establish the LS Medical Affairs Division within the LS Business Unit. The new division will strategically plan and promote clinical performance testing within the scope of obtaining approval to manufacture and sell in vitro diagnostic pharmaceuticals (regulatory approval).
  2. Buttressing the Global Governance Structure
    1. Reinforcing the Group Governance Function to Enhance Management Quality
      • To realize a governance function that responds to a rapidly changing environment, we will integrate the internal control and risk management functions and establish the Internal Control Division as the entity dedicated to these functions.

Organizational Structure (Changes are in red.)

Organizational Structure (FY2019)

2 Personnel Changes and Appointments

(1)

Appointments of Senior Executive Officers (Promotions)

Name

New Position

Current Position

Tomokazu

Senior Executive Officer

Executive Officer

Yoshida

Kensuke Iizuka

Senior Executive Officer

Executive Officer

(2)

Appointments of Executive Officers (Newly Appointed)

Name

New Position

Current Position

Alain Baverel

Executive Officer

CEO, Sysmex Europe GmbH

(3)

Retirement of Executive Officers (Completion of Contract Term)

Name

New Position

Current Position

John Kershaw

Senior Executive Officer

(4) Changes in Operating and Functional Changes of Executive Officers

Name

New Position

Current Position

Kaoru Asano

Member of the Managing Board and

Member of the Managing Board and

Senior Executive Officer

Senior Executive Officer

Senior Managing Director

Senior Managing Director

COO LS Business Unit(*1) and CTO

COO LS Business Unit and CTO

In charge of Corporate R&D(*2)

In charge of;

Vice President of

LS Business Div.

Medicaroid Corporation

Clinical Innovation Div.

LS Business Development Dept.

LS Medical Affairs Dept.

Technology Strategy Div.

Central Research Laboratories

System Technologies Laboratory

Bio-Diagnostic Reagent Technology

Center

Intellectual Property Div.

Scientific Affairs Div.

MR Business Development Div.

Medicaroid Corporation

Sysmex Engineering Co., Ltd.

Creative Nanosystems Corporation

Sysmex R&D Center Europe GmbH

Vice President of

Medicaroid Corporation

Kenji

Member of the Managing Board and

Member of the Managing Board and

Tachibana

Senior Executive Officer

Senior Executive Officer

Senior Managing Director

Senior Managing Director

COO IVD Business Unit(*3)

COO IVD Business Unit

In charge of;

Business Strategy Development Div.

HU Business Development Div.

ICH Business Development Div.

Engineering 1 Div.

Engineering 2 Div.

JEA Region Div.

Sales and Marketing East / Japan Div.

Sales and Marketing West / Japan Div.

Global Support Div.

Technology HR Development Dept.

Development Administration Dept.

Iwane Matsui

Member of the Managing Board and

Member of the Managing Board and

Senior Executive Officer

Senior Executive Officer

Managing Director

Managing Director

In charge of Japan and

In charge of;

International Business(*4)

JEA Region Div.

Sales and Marketing East / Japan Div.

Sales and Marketing West / Japan Div.

Global Support Div.

Sysmex TMC Co., Ltd.

Sysmex CNA Co., Ltd.

Sysmex America, Inc.

Sysmex Europe GmbH

Sysmex Shanghai Ltd.

Sysmex Asia Pacific Pte Ltd.

Sysmex Korea Co., Ltd.

Sysmex Taiwan Co., Ltd.

Name

New Position

Current Position

Hiroshi Kanda

Member of the Managing Board and

Member of the Managing Board and

Senior Executive Officer

Senior Executive Officer

Managing Director

Managing Director

IVD Business Unit

IVD Business Unit

In charge of IVD Business(*5)

In charge of;

Business Strategy Development Div.

HU Business Development Div.

ICH Business Development Div.

Sysmex Partec GmbH

HYPHEN BioMed, SAS

Sysmex Wuxi Co., Ltd.

Mamoru

Senior Executive Officer

Senior Executive Officer

Kubota

LS Business Unit

LS Business Unit

In charge of LS Business(*6)

In charge of;

LS Business Div.

Clinical Innovation Div.

LS Business Development Dept.

LS Medical Affairs Dept.

RIKEN GENESIS CO., LTD.

Sysmex Inostics GmbH

Oxford Gene Technology IP Limited

Tomokazu

Senior Executive Officer

Executive Officer

Yoshida

Executive Vice President of

Executive Vice President of

Central Research Laboratories,

Central Research Laboratories,

MR Business Development

MR Business Development

Director of Medicaroid Corporation

Director of Medicaroid Corporation

Kensuke Iizuka

Senior Executive Officer

Executive Officer

Deputy in charge of

Deputy in charge of;

Corporate Staff(*7)

Human Resources Div.

General Affairs Div.

Sysmex Business Support Co., Ltd.

Sysmex Harmony Co., Ltd.

Executive Vice President of

Human Resources Div.

Frank

Executive Officer

Executive Officer

Buescher

CEO, Sysmex Asia Pacific Pte Ltd.

CEO, Sysmex Asia Pacific Pte Ltd.

Executive Vice President of

Caresphere Innovation Div.

Alain Baverel

Executive Officer

CEO, Sysmex Europe GmbH

CEO, Sysmex Europe GmbH

  1. LS Business Div., Clinical Innovation Div., LS Medical Affairs Div., LS Business Development Dept.
  2. Technology Strategy Div., Central Research Laboratories, System Technologies Laboratory, Bio-Diagnostic Reagent Technology Center, Intellectual Property Div., Scientific Affairs Div., MR Business Development Div. Medicaroid Corporation, Sysmex Engineering Co.,Ltd., Creative Nanosystems Corporation, Sysmex R&D Center Americas, Inc., Sysmex R&D Center Europe GmbH
  3. Business Strategy Development Div., HU Business Development Div., ICH Business Development Div., Caresphere Innovation Div., Engineering 1 Div., Engineering 2 Div., JEA Region Div., Sales and Marketing East / Japan Div., Sales and Marketing West / Japan Div., Global Support Div., Technology HR Development Dept., Development Administration Dept.
  4. JEA Region Div., Sales and Marketing East / Japan Div., Sales and Marketing West / Japan Div., Global Support Div.
    Sysmex TMC Co., Ltd., Sysmex CNA Co., Ltd., Sysmex America, Inc., Sysmex Europe GmbH, Sysmex Shanghai

Ltd., Sysmex Asia Pacific Pte Ltd., Sysmex Korea Co., Ltd., Sysmex Taiwan Co., Ltd.

  1. Business Strategy Development Div., HU Business Development Div., ICH Business Development Div., Caresphere Innovation Div.
    Sysmex Partec GmbH, Sysmex CNA Co., Ltd., Sysmex New Zealand Ltd., HYPHEN BioMed, SAS, Sysmex Wuxi Co., Ltd
  2. LS Business Div., Clinical Innovation Div., LS Medical Affairs Div., LS Business Development Dept., RIKEN GENESIS CO., LTD., Sysmex Inostics GmbH, Oxford Gene Technology IP Limited
  3. Corporate Business Planning Div., Corporate Communication Div., Corporate Business Administration Div., Human Resources Div., General Affairs Div., Corporate Executive Office
    Sysmex Business Support Co., Ltd., Sysmex Harmony Co., Ltd.

Attachments

  • Original document
  • Permalink

Disclaimer

Sysmex Corporation published this content on 09 March 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 March 2020 06:32:04 UTC